Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials
Zhang L, Yang L, Shergis J, Zhang L, Zhang AL, Guo X, Qin X, Johnson D, Liu X, Lu C, Xue CC, Mao W · BMJ Open · 2019 April
DOI 10.1136/bmjopen-2018-025653
Objective
To investigate the efficacy and safety of oral Chinese herbal medicine (CHM) as an adjunctive treatment for diabetic kidney disease (DKD) in terms of mortality, progression to end-stage kidney disease (ESKD), albuminuria, proteinuria, and kidney function.
Conclusions
The study concludes that CHM, when used as an adjunct to conventional treatments, shows greater reduction in albuminuria and improved glomerular filtration rate in DKD patients.
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
